Time to Listen: What the Experts Have to Say About Safe Opioid Prescribing and Addiction Treatment
Premiere Date: Monday, April 15, 2019This activity offers CE credit for:
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
- ABIM (MOC)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, March 31, 2022
Note: Credit Is No Longer Available
| Addressing the Opioid Epidemic Faculty , |
The data and trends illustrating the impact of opioids on the United States are staggering. From July 2016 through September 2017, the Centers for Disease Control and Prevention (CDC) reported a 30% increase in overdoses among men and a 24% increase among women.
In December 2018, the Opioid Healthcare Provider/Advocacy Working Group convened for a two-day advisory board meeting with representatives from the primary care, pain management, oral surgery, orthopedic surgery, addiction, and physician assistant healthcare provider community, and the DEA Educational Foundation, to address the opioid epidemic and create actionable steps to promote appropriate and responsible prescribing for individuals with acute and chronic pain to curb the impact of the growing crisis facing our communities.
This CME Outfitters Monograph features insight from this panel of faculty experts on the challenges, consequences, and opportunities for the development of education to help meet the pain management needs of patients amid rising concerns of addiction and diversion.
At the end of this CE activity, participants should be able to:
- Recognize the growing burden of the opioid epidemic and the role of all stakeholders in addressing the opioid epidemic in their community.
- Apply knowledge of acute and chronic pain pathways and underlying mechanisms to clinical assessment and appropriate management of pain.
- Upon evaluation of your current clinical workflow for opioid prescribing, practice strategies to optimize safe and competent prescribing and minimize potential for abuse and diversion.
- Educate patients about their pain to optimize safe and effective, multimodal treatment plans.
- Integrate in practice concepts from novel programs in the community to address opioid overdose and treat patients with opioid use disorder (OUD).
Supported by an educational grant from Johnson & Johnson.
Physicians, dentists, physicians assistants, nurse practitioners, nurses, and pharmacists.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for1 contact hours
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.1 contact hours (0.10CEUs) UniversalActivity Number:Enduring: JA0007185-0000-21-136-H08-P Type: knowledge-based
ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Learning Format
Enduring material
Post-tests, credit request forms, and activity evaluation must be completed online. (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). this website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.cmeoutfitters.com/technical.asp.
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Gold has no disclosures to report.
Dr. Abubaker has no disclosures to report.
Mr. Alden has no disclosures to report.
Ms. Judd reports that she is on the speakers bureau for Alkermes; Neurocrine Biosciences, Inc.; Otsuka America Pharmaceutical, Inc.; Sunovion Pharmaceuticals Inc. She is on the advisory board for ACADIA Pharmaceuticals Inc.; Neurocrine Biosciences, Inc.
Dr. Mir reports that he is a consultant for OrthoGrid Systems, Inc.; Smith & Nephew; StabilizOrtho; Trice Medical; Zimmer Biomet.
Dr. Schmidt has no disclosures to report.
Dr. Stanos reports that he receives research support from Grunenthal and is a consultant for SCILEX Pharmaceuticals, Inc.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
CNW-039-041519-57
